MCLEAN, VA / ACCESS Newswire / September 9, 2025 / Gladstone Capital Corporation (NASDAQ:GLAD) (the “Company”) today ...
The Daily Overview on MSN
7 remote roles with zero Zoom forever
In today’s digital age, many remote workers are seeking roles that offer flexibility without the constant need for video ...
Two years after buying CinCor Pharma for $1.3 billion, AstraZeneca has reported that the main asset in the deal, for uncontrolled or treatment-resistant hypertension, has cleared a phase 3 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback